Zimbabwe has turned down a significant US health deal worth $367m (272 million pounds) over five years due to Washington's request for sensitive information.
This move was revealed after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesperson has since explained that the United States was seeking genetic material for scientific study and commercial purposes while was unwilling to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for continued dialogue to reach a deal suitable to all parties so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This rejection follows a similar case in neighbouring Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
After returning to office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.
According to statements, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent promise of access to any medical innovations – like new medicines or tests – that might be developed from that provided information," his statement read.
"Put simply, our country would provide the raw materials for scientific discovery without any assurance that the end products would be available to our citizens should a future pandemic arise."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of one-on-one deals were undermining frameworks already established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage future global health emergencies.
"This system is designed to guarantee that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future co-operation might be designed in a way that respects the independence and interests of each country."
Health Experts Response
A leading public health body stated it acknowledged the government's concerns, but recommended that talks should continue given that much of the country's HIV programmes were funded by external financing.
"Where specific concerns exist, such as those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it said.
The situation underscores the continuing challenges between receiving much-needed international aid and safeguarding a country's data in an increasingly interconnected world.